Drusen are Cold Spots for Proteolysis: Expression of Matrix Metalloproteinases and Their Tissue Inhibitor Proteins in Age-related Macular Degeneration
- 1 January 2002
- journal article
- Published by Elsevier in Experimental Eye Research
- Vol. 74 (1) , 141-154
- https://doi.org/10.1006/exer.2001.1112
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Simple and Complex ABCR: Genetic Predisposition to Retinal DiseaseAmerican Journal of Human Genetics, 2000
- Ongoing trials with matrix metalloproteinase inhibitorsExpert Opinion on Investigational Drugs, 2000
- A Potential Role for Immune Complex Pathogenesis in Drusen FormationExperimental Eye Research, 2000
- Tissue inhibitors of metalloproteinases: evolution, structure and functionBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000
- Drusen in Age-Related Macular DegenerationSurvey of Ophthalmology, 1999
- Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosaBritish Journal of Ophthalmology, 1998
- Mutation of the Stargardt Disease Gene ( ABCR ) in Age-Related Macular DegenerationScience, 1997
- Localization of tissue inhibitor of metalloproteinases-3 in neurodegenerative retinal diseaseNeuroReport, 1997
- Specific, High Affinity Binding of Tissue Inhibitor of Metalloproteinases-4 (TIMP-4) to the COOH-terminal Hemopexin-like Domain of Human Gelatinase AJournal of Biological Chemistry, 1997
- Sibling correlations and segregation analysis of age‐related maculopathy: The beaver dam eye studyGenetic Epidemiology, 1994